Related Experiment Videos
Trifluoperazine plasma levels and clinical response.
P G Janicak1, J I Javaid, R P Sharma
1Illinois State Psychiatric Institute, Chicago 60612.
Journal of Clinical Psychopharmacology
|October 1, 1989
Summary
This study found an optimal trifluoperazine plasma level for treating psychosis. Higher or lower levels were less effective, showing an inverted U-shaped response in patients with schizophrenia.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Neuroscience
Background:
- Schizophrenia and other psychotic disorders are complex mental health conditions.
- Effective treatment relies on optimizing medication dosage and monitoring plasma levels.
- Trifluoperazine is an antipsychotic medication used in managing psychotic symptoms.
Purpose of the Study:
- To investigate the relationship between trifluoperazine plasma levels and clinical response in acutely psychotic patients.
- To determine if an optimal therapeutic window exists for trifluoperazine treatment.
Main Methods:
- 36 acutely psychotic inpatients (30 with schizophrenia) were enrolled.
- Patients underwent a washout period before starting trifluoperazine (5 mg BID).
- Trifluoperazine plasma levels were measured on days 11 and 15, correlated with Brief Psychiatric Rating Scale scores.
Main Results:
- An inverted U-shaped relationship was observed between trifluoperazine plasma levels and symptom improvement.
- This suggests that both too low and too high plasma concentrations may be less effective.
Conclusions:
- There appears to be an optimal plasma concentration range for trifluoperazine in treating acute psychosis.
- Therapeutic drug monitoring of trifluoperazine levels may enhance treatment efficacy.